Loading...
Cryoport Inc (CYRX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown improvements in financial performance, the lack of clear positive trading signals, neutral insider/hedge fund activity, and no recent news or catalysts make it prudent to hold off on buying this stock until stronger signals or catalysts emerge.
The MACD is positive and expanding (0.0155), indicating a mild bullish trend. RSI is neutral at 49.838, and moving averages are converging, suggesting no clear directional trend. The stock is trading near its pivot level (8.422) with resistance at 8.739 and support at 8.105, showing limited volatility.

The company's financials for Q3 2025 show significant YoY improvements: revenue increased by 15.44%, net income improved by 648.37%, and EPS rose by 800%. Gross margin also increased to 48.21%.
No recent news or event-driven catalysts. Insider and hedge fund activity are neutral, and there is no recent congress trading data. The stock lacks strong trading signals from Intellectia Proprietary Trading Signals.
In Q3 2025, Cryoport Inc's revenue increased to $44.23M (up 15.44% YoY). Net income improved significantly to -$8.94M (up 648.37% YoY), and EPS increased to -0.18 (up 800% YoY). Gross margin rose to 48.21% (up 5.96% YoY).
No data available for analyst ratings or price target changes.